secwatch / observer
8-K filed March 25, 2026, 7:59 PM ET ticker MCHX CIK 0001224133
earnings confidence high sentiment neutral materiality 0.70

Marchex Q4 revenue down to $10.8M, guides Q1 adj. EBITDA >$500k; Archenia deal on track for June 2026

MARCHEX INC

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

MARCHEX INC reported first quarter 2026 and second quarter 2026 and full year 2026 results: revenue in the first quarter of 2026 Marchex currently anticipates that revenue will be in the range of fourth quarter 2025 leve.

Period
first quarter 2026 and second quarter 2026 and full year 2026
Revenue
in the first quarter of 2026 Marchex currently anticipates that revenue will be in the range of fourth quarter 2025 leve
Result
guidance update
Exact text from the filing
Revenue in the first quarter of 2026 reflects the migration revenue dilution from the final platform switch over in December 2025, which impacted revenue run rates entering 2026. With this noted, in the first quarter of 2026 Marchex currently anticipates that revenue will be in the range of fourth quarter 2025 levels, and that Adjusted EBITDA will be $500,000 or more.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.92

MARCHEX INC reported fourth quarter and full year ended December 31, 2025 results: revenue GAAP revenue was $10.8 million for the fourth quarter of 2025, compared to $11.9 million for the fourth quarter of 2024., net income Net loss was $2.3 million for the fourth quarter of 2025 or $(0.05) per diluted share, compared to a net loss of $1.9 mi, EPS Net loss was $2.3 million for the fourth quarter of 2025 or $(0.05) per diluted share, compared to a net loss of $1.9 mi.

Period
fourth quarter and full year ended December 31, 2025
Revenue
GAAP revenue was $10.8 million for the fourth quarter of 2025, compared to $11.9 million for the fourth quarter of 2024.
Net income
Net loss was $2.3 million for the fourth quarter of 2025 or $(0.05) per diluted share, compared to a net loss of $1.9 mi
EPS
Net loss was $2.3 million for the fourth quarter of 2025 or $(0.05) per diluted share, compared to a net loss of $1.9 mi
Result
reported results
Exact text from the filing
Marchex Announces Fourth Quarter and Full Year 2025 Results and Archenia Transaction Update SEATTLE, WA – March 25, 2026 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversation intelligence to provide actionable insights derived from prescriptive vertical market data analytics, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Q4 2025 and Full Year 2025 Financial Highlights • GAAP revenue was $10.8 million for the fourth quarter of 2025, compared to $11.9 million for the fourth quarter of 2024. GAAP revenue was $45.4 million for 2025, compared to $48.1 million for 2024. • Net loss was $2.3 million for the fourth quarter of 2025 or $(0.05) per diluted share, compared to a net loss of $1.9 million or $(0.04) per diluted share for the fourth quarter of 2024. Net loss was $5.2 million for 2025 or $(0.12) per diluted share, compared to a net loss of $4.9 million for 2024 or $(0.11) per diluted share.
View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

MARCHEX INC filing history →

Source: SEC EDGAR
accession 0001193125-26-124166
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.